Cure Alzheimer's Fund Cure Alzheimer's Fund

Curcumin Collaborative Project

2010

This collaborative project will identify and characterize novel curcumin-like derivatives for the treatment and prevention of Alzheimer’s disease. The purpose of the study is to develop means of overcoming obstacles to rapid breakdown and creating methodologies for precisely delivering curcumin derivatives to appropriate locations within the brain.

Drug Discovery Drug Screening Projects Rudy Tanzi William Klunk

Funding to Date

$400,000

Focus

Drug Discovery, Drug Screening Projects

Researchers

Rudy Tanzi, Ph.D.

William Klunk, M.D., Ph.D.

Related Content:


Exploring Novel Drug Candidates for Alzheimer’s Disease Through Integrative Pathway Analysis and Validation in 3D Cellular Models Doo Yeon Kim Luisa Quinti 2024-02-01 Development of Small Molecule Inhibitors of Cholesterol 25-hydroxylase Anil Cashikar Bahaa Elgendy 2024-02-01 Microbiome Consortium: Microbial Profiling of Human Brain and Gut Microbiomes in Alzheimer’s Disease Rudy Tanzi Nanda Kumar Navalpur Shanmugam 2023-11-02 Validation and Characterization of Compounds Modulating Neuroinflammation and Amyloid Beta Uptake in Microglial Cells Ana Griciuc Luisa Quinti 2023-10-25 Identification and Development of CD33 Inhibitors and Pre-RNA Splicing Modulators Subhash Sinha 2023-10-25 Role of CD8+ T Cell–Glial Interactions in Mediating Alzheimer’s Disease Pathogenesis Mehdi Jorfi Joseph Park Rudy Tanzi 2023-09-19 Development of a Multicellular Brain Model to Study Brain-Vascular-Peripheral Immune Cells Crosstalk in Alzheimer’s Disease Mehdi Jorfi Joseph Park Rudy Tanzi 2022-02-17 Alzheimer’s Disease Drug Discovery and Development Consortium: Blocking Synaptotoxicity in Alzheimer’s Three-Dimensional Models Weiming Xia 2022-02-17